摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3S,4S,5R)-3,4,5-tris(benzyloxy)tetrahydro-2H-thiopyran | 791627-52-6

中文名称
——
中文别名
——
英文名称
(3S,4S,5R)-3,4,5-tris(benzyloxy)tetrahydro-2H-thiopyran
英文别名
1,5-anhydro-2,3,4-tri-O-benzyl-5-thioxylitol
(3S,4S,5R)-3,4,5-tris(benzyloxy)tetrahydro-2H-thiopyran化学式
CAS
791627-52-6
化学式
C26H28O3S
mdl
——
分子量
420.573
InChiKey
DJOHGGXHKMIQKZ-GPOLMCQNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.49
  • 重原子数:
    30.0
  • 可旋转键数:
    9.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    27.69
  • 氢给体数:
    0.0
  • 氢受体数:
    4.0

反应信息

  • 作为反应物:
    描述:
    (3S,4S,5R)-3,4,5-tris(benzyloxy)tetrahydro-2H-thiopyranN-氯代丁二酰亚胺间氯过氧苯甲酸 作用下, 以 四氯化碳二氯甲烷 为溶剂, 反应 18.5h, 生成 (3R,4S,5S)-2-chloro-3,4,5-tris(benzyloxy)tetrahydrothiopyran 1,1-dioxide
    参考文献:
    名称:
    Convenient one-pot synthesis of thiosugars and their efficient conversion to polyoxygenated cycloalkenes
    摘要:
    A convenient synthesis of polyoxygenated tetrahydrothiopyrans and thiepanes from various alditol derivatives with xylo, ribo, manno, gluco, galacto, and fuco configurations is described. The preparation started from the corresponding partially protected alditols and proceeded in a 'one-pot' manner to afford the final products in 80%-95% yield. Furthermore, thiosugar compounds 2b, 2d, and 2g were converted to the optically pure polyoxygenated cycloalkenes through Ramberg-Backlund reaction in moderate to good overall yield. The procedures can be used for the preparation of polyoxygenated thiosugars and cycloalkenes on a relatively large scale. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2012.03.086
  • 作为产物:
    参考文献:
    名称:
    烷基化脱氧野尻霉素和 1,5-Dideoxy-1,5-亚氨基木糖醇类似物的合成:极性侧链修饰、锍和硒杂原子变体、构象分析和作为糖苷酶抑制剂的评估
    摘要:
    报道了 N-烷基化脱氧野尻霉素和具有 D-或 L-赤藓糖醇-3-硫酸酯官能化 N-取代基的 1,5-dideoxy-1,5-亚氨基木糖醇衍生物的合成。所用的烷基化剂是环状硫酸盐衍生物,由此选择性地攻击受阻最小的一级中心处的氮原子,得到所需的铵盐。在水溶液中,这些盐在铵中心的构型不稳定。铵盐的锍和/或硒鎓类似物通过类似反应制备。硫属元素盐是作为非对映异构体的混合物获得的,在某些情况下是可分离的,仅在构型稳定的硫或硒原子的立体化学上有所不同。通过详细的 NMR 实验获得了每种化合物的构型和构象的证据。这些化合物是 salacinol 的六元环类似物,是一种已知的锍盐葡萄糖苷酶抑制剂。对目标化合物对葡糖苷酶葡糖淀粉酶 G2 的酶抑制作用的评估表明,这些化合物要么是无活性的,要么最多只是麦芽糖水解的弱抑制剂。
    DOI:
    10.1021/ja0482076
点击查看最新优质反应信息

文献信息

  • Glycosidase inhibitors and methods of synthesizing same
    申请人:Pinto Mario Brian
    公开号:US20050065139A1
    公开(公告)日:2005-03-24
    A method for synthesizing Salacinol, its stereoisomers, and analogues, homologues and other derivatives thereof potentially useful as glycolsidase inhibitors. The compounds of the invention may have the general formula (I) or (II): The synthetic schemes comprise reacting a cyclic sulfate with a 5-membered ring sugar containing a heteroatom (X). The heteroatom preferably comprises sulfur, selenium, or nitrogen. The cyclic sulfate and ring sugar reagents may be readily prepared from carbohydrate precursors, such as D-glucose, L-glucose, D-xylose and L-xylose. The target compounds are prepared by opening of the cyclic sulfates by nucleophilic attack of the heteroatoms on the 5-membered ring sugars. The resulting heterocyclic compounds have a stable, inner salt structure comprising a heteroatom cation and a sulfate anion. The synthetic schemes yield various stereoisomers of the target compounds in moderate to good yields with limited side-reactions.
    一种合成Salacinol及其立体异构体、类似物、同系物和其他衍生物的方法,可能用作糖苷酶抑制剂。本发明的化合物可能具有一般式(I)或(II):合成方案包括将环状硫酸酯与含有杂原子(X)的5元环糖反应。杂原子优选包括或氮。环状硫酸酯和环糖试剂可以从碳水化合物前体(如D-葡萄糖、L-葡萄糖D-木糖L-木糖)中轻松制备。目标化合物是通过杂原子对5元环糖的亲核攻击打开环状硫酸酯来制备的。所得的杂环化合物具有稳定的内盐结构,包括一个杂原子阳离子和一个硫酸酯阴离子。合成方案以中等至良好的产率产生目标化合物的各种立体异构体,副反应有限。
  • GLYCOSIDASE INHIBITORS AND METHODS OF SYNTHESIZING SAME
    申请人:SIMON FRASER UNIVERSITY
    公开号:EP1653945A2
    公开(公告)日:2006-05-10
  • US8389565B2
    申请人:——
    公开号:US8389565B2
    公开(公告)日:2013-03-05
  • [EN] GLYCOSIDASE INHIBITORS AND METHODS OF SYNTHESIZING SAME<br/>[FR] INHIBITEURS DE LA GLYCOSIDASE ET LEURS PROCEDES DE SYNTHESE
    申请人:UNIV FRASER SIMON
    公开号:WO2004113289A2
    公开(公告)日:2004-12-29
    A method for synthesizing Salacinol, its stereoisomers, and analogues, homologues and other derivatives thereof potentially useful as glycolsidase inhibitors. The compounds of the invention may have the general formula (I) or (II): The synthetic schemes comprise reacting a cyclic sulfate with a 5-membered ring sugar containing a heteroatom (X). The heteroatom preferably comprises sulfur, selenium, or nitrogen. The cyclic sulfate and ring sugar reagents may be readily prepared from carbohydrate precursors, such as D-glucose, L-glucose, D-xylose and L-xylose. The target compounds are prepared by opening of the cyclic sulfates by nucleophilic attack of the heteroatoms on the 5-membered ring sugars. The resulting heterocyclic compounds have a stable, inner salt structure comprising a heteroatom cation and a sulfate anion. The synthetic schemes yield various stereoisomers of the target compounds in moderate to good yields with limited side-reactions.
  • [EN] GLYCOSIDASE INHIBITORS AND METHODS OF SYNTHESIZING SAME<br/>[FR] INHIBITEURS DE GLYCOSIDASES ET PROCÉDÉS DE SYNTHÈSE DE CEUX-CI
    申请人:UNIV FRASER SIMON
    公开号:WO2007098597A1
    公开(公告)日:2007-09-07
    [EN] Methods for synthesizing Salacinol, its stereoisomers, and analogues, homologues and other derivatives thereof potentially useful as glycosidase inhibitors are described. In some embodiments the compounds of the invention may have the general formula (I) or (II). The synthetic schemes may comprise reacting a cyclic sulfate with a 5-membered ring sugar containing a heteroatom (X). The heteroatom preferably comprises sulfur, selenium, or nitrogen. The cyclic sulfate and ring sugar reagents may be readily prepared from carbohydrate precursors, such as D-glucose, L-glucose, D-xylose and L-xylose. The target compounds are prepared by opening of the cyclic sulfates by nucleophilic attack of the heteroatoms on the 5-membered ring sugars. The resulting heterocyclic compounds have a stable, inner salt structure comprising a heteroatom cation and a sulfate anion. The synthetic schemes yield various stereoisomers of the target compounds in moderate to good yields with limited side-reactions. Chain-extended analogues of Salacinol are also described.
    [FR] L'invention concerne des procédés servant à synthétiser du Salacinol, ses stéréoisomères et des analogues, des homologues et autres dérivés de ceux-ci potentiellement utiles en tant qu'inhibiteurs de glycosidases. Dans certains modes de réalisation, les composés de l'invention peuvent répondre à la formule générale (I) ou (II). Les schémas de synthèse peuvent consister à faire réagir un sulfate cyclique avec un sucre cyclique à 5 chaînons contenant un hétéroatome (X). L'hétéroatome est de préférence le soufre, le sélénium ou l'azote. On peut aisément préparer les réactifs que sont le sulfate cyclique et le sucre cyclique à partir de précurseurs de type glucides tels que le D-glucose, le L-glucose, le D-xylose et le L-xylose. On prépare les composés cibles en ouvrant les sulfates cycliques par attaque nucléophile des hétéroatomes sur les sucres cycliques à 5 chaînons. Les composés hétérocycliques résultants ont une structure de sel interne stable comprenant un cation d'un hétéroatome et un anion sulfate. Les schémas de synthèse produisent différents stéréoisomères des composés cibles avec des rendements de production moyens à bons et avec des réactions secondaires limitées. L'invention concerne également des analogues par extension de chaîne du Salacinol.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫